NEET MDS Lessons
General Medicine
COPD
- Reid's index: Used in chronic bronchitis
- Emphysema features: ↓DLCO, weight loss, pneumothorax risk
- Chronic bronchitis: Polycythemia
- GOLD criteria: COPD severity assessment
- BODE index: Lung transplant evaluation
Sleep Apnea
Definition: Breathing pause ≥10 seconds during sleep
ASTHMA
Diagnosis & Pathophysiology
- Best diagnostic test: Demonstration of reversible obstruction
- Small airways involved
- Idiosyncratic asthma: Normal IgE levels
- Aspirin-sensitive asthma: Associated with nasal polyps
Key Points
- Charcot-Leyden crystals: Eosinophil granules
- Nebulizer droplet size: <2.5 μm
- Most severe attack indicator: Bradycardia
- Montelukast: NOT useful in acute bronchial asthma
Localized Aggressive Periodontitis and Necrotizing Ulcerative Gingivitis
Localized Aggressive Periodontitis (LAP)
Localized aggressive periodontitis, previously known as localized juvenile periodontitis, is characterized by specific microbial profiles and clinical features.
- Microbiota Composition:
- The microbiota associated with LAP is predominantly composed of:
- Gram-Negative, Capnophilic, and Anaerobic Rods.
- Key Organisms:
- Actinobacillus actinomycetemcomitans: The main organism involved in LAP.
- Other significant organisms include:
- Porphyromonas gingivalis
- Eikenella corrodens
- Campylobacter rectus
- Bacteroides capillus
- Spirochetes (various species).
- Viral Associations:
- Herpes viruses, including Epstein-Barr Virus-1 (EBV-1) and Human Cytomegalovirus (HCMV), have also been associated with LAP.
- The microbiota associated with LAP is predominantly composed of:
Necrotizing Ulcerative Gingivitis (NUG)
- Microbial Profile:
- NUG is characterized by high levels of:
- Prevotella intermedia
- Spirochetes (various species).
- NUG is characterized by high levels of:
- Clinical Features:
- NUG presents with necrosis of the gingival tissue, pain, and ulceration, often accompanied by systemic symptoms.
Microbial Shifts in Periodontal Disease
When comparing the microbiota across different states of periodontal health, a distinct microbial shift can be identified as the disease progresses from health to gingivitis to periodontitis:
-
From Gram-Positive to Gram-Negative:
- Healthy gingival sites are predominantly colonized by gram-positive bacteria, while diseased sites show an increase in gram-negative bacteria.
-
From Cocci to Rods (and Later to Spirochetes):
- In health, cocci (spherical bacteria) are prevalent. As the disease progresses, there is a shift towards rod-shaped bacteria, and in advanced stages, spirochetes become more prominent.
-
From Non-Motile to Motile Organisms:
- Healthy sites are often dominated by non-motile bacteria, while motile organisms increase in number as periodontal disease develops.
-
From Facultative Anaerobes to Obligate Anaerobes:
- In health, facultative anaerobes (which can survive with or without oxygen) are common. In contrast, obligate anaerobes (which thrive in the absence of oxygen) become more prevalent in periodontal disease.
-
From Fermenting to Proteolytic Species:
- The microbial community shifts from fermentative bacteria, which primarily metabolize carbohydrates, to proteolytic species that break down proteins, contributing to tissue destruction and inflammation.
Gingivitis
Gingivitis is an inflammatory condition of the gingiva that can progress through several distinct stages. Understanding these stages is crucial for dental professionals in diagnosing and managing periodontal disease effectively. This lecture will outline the four stages of gingivitis, highlighting the key pathological changes that occur at each stage.
I. Initial Lesion
- Characteristics:
- Increased Permeability: The microvascular bed in the gingival tissues becomes more permeable, allowing for the passage of fluids and immune cells.
- Increased GCF Flow: There is an increase in the flow of gingival crevicular fluid (GCF), which is indicative of inflammation and immune response.
- PMN Cell Migration: The migration of
polymorphonuclear leukocytes (PMNs) is facilitated by various adhesion
molecules, including:
- Intercellular Cell Adhesion Molecule 1 (ICAM-1)
- E-selectin (ELAM-1) in the dentogingival vasculature.
- Clinical Implications: This stage marks the beginning of the inflammatory response, where the body attempts to combat the initial bacterial insult.
II. Early Lesion
-
Characteristics:
- Leukocyte Infiltration: There is significant infiltration of leukocytes, particularly lymphocytes, into the connective tissue of the junctional epithelium.
- Fibroblast Degeneration: Several fibroblasts within the lesion exhibit signs of degeneration, indicating tissue damage.
- Proliferation of Basal Cells: The basal cells of the junctional and sulcular epithelium begin to proliferate, which may be a response to the inflammatory process.
-
Clinical Implications: This stage represents a transition from initial inflammation to more pronounced tissue changes, with the potential for further progression if not managed.
III. Established Lesion
-
Characteristics:
- Predominance of Plasma Cells and B Lymphocytes: There is a marked increase in plasma cells and B lymphocytes, indicating a more advanced immune response.
- Increased Collagenolytic Activity: The activity of collagen-degrading enzymes increases, leading to the breakdown of collagen fibers in the connective tissue.
- B Cell Subclasses: The B cells present in the established lesion are predominantly of the IgG1 and IgG3 subclasses, which are important for the immune response.
-
Clinical Implications: This stage is characterized by chronic inflammation, and if left untreated, it can lead to further tissue destruction and the transition to advanced lesions.
IV. Advanced Lesion
-
Characteristics:
- Loss of Connective Tissue Attachment: There is significant loss of connective tissue attachment to the teeth, which can lead to periodontal pocket formation.
- Alveolar Bone Loss: Extensive damage occurs to the alveolar bone, contributing to the overall loss of periodontal support.
- Extensive Damage to Collagen Fibers: The collagen fibers in the gingival tissues are extensively damaged, further compromising the structural integrity of the gingiva.
- Predominance of Plasma Cells: Plasma cells remain predominant, indicating ongoing immune activity and inflammation.
-
Clinical Implications: This stage represents the transition from gingivitis to periodontitis, where irreversible damage can occur. Early intervention is critical to prevent further progression and loss of periodontal support.
| Type | Features |
|---|---|
| Unconjugated | Absent in urine (bound to albumin); hemolysis |
| Conjugated | Seen in Dubin-Johnson |
| Diagnosis | BSP test (Dubin-Johnson) |
| Genetics | Crigler-Najjar Type II – Autosomal recessive |
| Cholestasis | ↑ 5’-nucleotidase |
| Hypothyroid | ↓ Alk Phos |
🧬 Risk Factors
- Increased homocysteine levels
- Raised lipoprotein(a)
- Nephrotic syndrome increases CAD risk
- Unsaturated fatty acid intake: Protective
- Best probability predictor in elderly: LDL/HDL ratio
⚕️ Diagnosis & Presentation
| Condition | Diagnostic Best Practice |
|---|---|
| Angina pectoris | History |
| Stable angina | Cardiac markers unchanged |
| Acute MI | Tall T wave (earliest ECG sign) |
| MI ≥12 hrs post-onset | Test of choice: Cardiac troponin |
| Prinzmetal’s angina | First-line agent: Nitrates |
| Intraoperative MI | Transesophageal echocardiography |
| Best biomarker of MI | Troponin T |
| WHO MI criteria | Echo not part of official criteria |
🧪 Enzymes & Drugs
- Enzyme ↑ at 4 – 6 hrs, ↓ in 3 – 4 days: CPK
- Stress ECHO agent: Dobutamine
- Intervention of choice: Streptokinase + Heparin
- Thrombolytics window: Within 12 hrs of MI
🚨 Prognosis & Complications
- Day 1: Maximum MI mortality
- Post-MI valvular lesion: Mitral regurgitation
- Best predictor of morbidity: LVEF
- Fatal thrombolysis complication: Intracranial hemorrhage
- LAD artery nicknamed: Widow’s artery
Infection Timeline Post-BMT
Phase I: Pre-engraftment (0-30 days)
- Earliest infection: Herpes Simplex Virus (HSV)
- Other pathogens: Bacteria, Candida, Aspergillus
- Risk factors: Neutropenia, mucositis, central lines
Phase II: Early post-engraftment (30-100 days)
- ~7th week (50 days): Interstitial Pneumonitis peak incidence
- Causes: CMV, Pneumocystis jirovecii, idiopathic
- GVHD: Acute graft-versus-host disease peak
Phase III: Late post-engraftment (>100 days)
- Chronic GVHD: Major concern
- Encapsulated bacteria: Due to functional asplenia
- Varicella-zoster virus: Reactivation common
Specific Infectious Complications
CMV Disease
- Timeline: 30-100 days post-BMT
- High risk: CMV+ recipient or donor
- Manifestations: Pneumonitis, gastroenteritis, retinitis
Interstitial Pneumonitis (IP)
- Peak incidence: ~7th week (50 days) post-BMT
- Types:
- CMV pneumonitis (most common infectious cause)
- Idiopathic IP
- Pneumocystis pneumonia
- Mortality: High, especially CMV pneumonitis
Prophylactic Strategies
- Antibacterial: Fluoroquinolones
- Antifungal: Fluconazole or newer azoles
- Antiviral: Acyclovir for HSV/VZV
- PCP prophylaxis: Trimethoprim-sulfamethoxazole
- CMV monitoring: Pre-emptive therapy based on viral load
GVHD Prevention
- Immunosuppression: Methotrexate + calcineurin inhibitors
- T-cell depletion: In some protocols
- HLA matching: Reduces risk significantly
Contraindications and Limitations
Gingivectomy
- Major Contraindication: When pocket bottom is apical to mucogingival junction
- Risk: Inadequate attached gingiva post-surgery
Curettage Protocol
- Prerequisite: Should always be preceded by scaling and root planing
- Rationale: Reduce bacterial load before surgical intervention
GTR (Guided Tissue Regeneration)
Membrane Placement Technique
- Apical Extension: 3-4mm apical to defect margin
- Lateral Extension: 2-3mm laterally beyond defect
- Objective: Exclude epithelial and connective tissue cells
Implant Considerations
Placement Guidelines
- Distance from Mental Foramen: ≥5mm to avoid nerve damage
- Primary Stability: Critical for osseointegration
Micro-movement Tolerance
- Critical Threshold: >150μm causes fibrous tissue formation instead of osseointegration
- Clinical Implication: Importance of proper implant stability